ClinConnect ClinConnect Logo
Search / Trial NCT05644821

Influence of Electronic Patient Reported Outcomes (ePROMs) in Surgical Therapy for Prostate Cancer on Postoperative Outcome

Launched by HEINRICH-HEINE UNIVERSITY, DUESSELDORF · Nov 30, 2022

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how using electronic Patient Reported Outcomes Measures (ePROMs) can help improve the recovery process for men undergoing surgery for prostate cancer. Specifically, the study aims to see if following patients closely with these electronic tools in the first year after their prostate surgery can help catch any postoperative symptoms early. The goal is to find out if this approach can lead to better management of issues like incontinence, overall symptom burden, quality of life, and how confident patients feel about their health.

To participate in this trial, men aged 18 and older who are planning to have their prostate removed due to cancer may be eligible. Participants need to be able to use a mobile device or computer, understand German, and complete electronic questionnaires, with help if needed. The trial is currently recruiting participants, and those who join can expect to use technology to report their health status regularly, which could help improve their recovery experience. It's important to note that those with severe health issues or pre-existing urinary incontinence may not qualify for this study.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • age ≥ 18 y
  • legal capacity
  • sufficient knowledge of the German language
  • prostate carcinoma, TNM T1-4 NX N0-1 M0-1c
  • primary radical prostatectomy planned
  • mobile input device or PC available
  • ability to either receive emails or install a special app on cell phone and receive push messages, with guidance or assistance if necessary
  • ability to complete electronic questionnaires, with guidance or assistance if necessary
  • Exclusion Criteria:
  • palliative treatment situation (life expectancy \< 1 year)
  • preoperative urinary incontinence (at least one pad per 24 hours)

About Heinrich Heine University, Duesseldorf

Heinrich-Heine University Düsseldorf is a leading academic institution dedicated to advancing medical research and education. Renowned for its innovative approach to healthcare and interdisciplinary collaboration, the university plays a pivotal role in clinical trials aimed at improving patient outcomes and translating scientific discoveries into clinical practice. With a robust infrastructure and a commitment to ethical standards, Heinrich-Heine University fosters an environment that supports cutting-edge research initiatives, contributing significantly to the advancement of medical knowledge and therapeutic interventions.

Locations

Bonn, North Rhine Westpahlia, Germany

Dortmund, North Rhine Westphalia, Germany

Düsseldorf, North Rhine Westphalia, Germany

Herne, North Rhine Westphalia, Germany

Münster, North Rhine Westphalia, Germany

Patients applied

0 patients applied

Trial Officials

Peter Albers, MD

Principal Investigator

University Clinic Düsseldorf, Urology

André Karger, MD

Study Director

University Clinic Düsseldorf, psychosomatic medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials